Summary
The effect of propranolol on furosemide-stimulated urinary prostaglandin E2 (PGE2) excretion and renal blood flow was evaluated in 12 patients with alcoholic liver cirrhosis. Plasma and urine were collected before and 60 min after furosemide 20 mgI with or without propranolol pretreatment, and plasma renin activity (PRA), plasma aldosterone concentration (PAC), urinary excretion of PGE2 and sodium were determined. The renal interlobar arterial Pulsatility Index (PI), as an index of resistance to blood flow, was also determined before and 60 min after furosemide administration with and without propranolol pretreatment, by using a duplex Doppler ultrasound (Hitachi EUB 565).
Urine volume and sodium excretion after furosemide administration were not influenced by the propranolol pretreatment. Furosemide administration significantly increased urinary PGE2 excretion, PRA and PAC, and these effects were significantly reduced by propranolol. Furosemide administration with or without propranolol significantly reduced renal interlobar arterial PI, the average reduction in PI being significantly lower after furosemide administration with propranolol pretreatment.
The results demonstrate that propranolol pretreatment significantly influenced the furosemide-induced increase in urinary PGE2 excretion and renal interlobar arterial blood flow in cirrhotic patients.
This is a preview of subscription content, log in via an institution to check access.
References
Lebrec D, Poynard T, Hillon P (1984) A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A final report. Hepatology 4: 355–338
Colombo M, DeFranchis R, Tommasini M, Sangiovanni A, Dioguardi N (1989) Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology 9: 433–438
Westaby D, Bihari DJ, Gimson AES, Crossley IR, Williams R (1984) Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 25:121–124
Buhler FR, Larage JH, Baer L, Vaughan ED, Brunner HR (1972) Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287:1209–1214
Wilkinson SP, Bernadi M, Smith IK, Jowett TP, Slater JDH, Williams R (1977) Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Gastroenterology 73: 659–663
Bataille C, Bercott E, Pariente EA, Valla D, Lebrec D (1984) Effects of propranolol on renal blood flow and renal function in patients with cirrhosis. Gastroenterology 86: 129–133
Abe K, Irokawa N, Yasujima M (1978) The kallikrein-kinin system and prostaglandins in the kidney: Their relation to furosemide-induced diuresis and to the renin-angiotensin-aldosterone system in man. Circ Res 43: 254–260
Mackay IG, Muir AL, Watson ML (1984) Contribution of prostaglandins to the systemic and renal vascular response to furosemide in normal man. Br J Clin Pharmacol 17:513–519
Fujimura A, Kajiyama H, Ebibara A (1987) The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects. Eur J Clin Pharmacol 31: 605–607
Stevens PE, Bolsin S, Gwyther SJ, Hanson ME, Boultbee JE, Kox W (1989) Practical use of duplex doppler analysis of the renal vasculature in critically ill patients. Lancet 1: 140–142
Burns PN (1987) The physical principles of doppler and spectral analysis. J Clin Ultrasound 15: 567–590
Jaffe BM, Behrman HR, Parker CW (1973) Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest 52: 398–405
Taylor KJW, Burns PN, Woodcock JP, Wells PNT (1985) Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis. Radiology 154: 487–493
Greene ER, Venters MD, Avasthi PA, Conn RL, Jahuke RW (1981) Noninvasive characterisation of renal artery blood flow. Kidney Int 20: 523–529
Greene ER, Avasthi PA, Hodges JW (1987) Noninvasive doppler assessment of renal artery stenosis and hemodynamics. JCU 15: 653–660
Attallah AA, Stahl RAK, Bloch DL, Lee JB (1979) Furosemide stimulates and saralasin inhibits renal prostaglandin E2 biosynthesis. Clin Res 27: 599A
Tan SY, Mulrow PJ (1977) Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab 45: 174–176
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ljubičić, N., Bilić, A., Plavšić, V. et al. Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis. Eur J Clin Pharmacol 43, 555–558 (1992). https://doi.org/10.1007/BF02285102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02285102